Rheumagen
Manufacturing · Colorado, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
12635 E Montview Blvd Ste 137, Aurora, C...Website
www.rheumagen.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About Rheumagen
RheumaGen is a private biotechnology company engineering a new class of therapeutics to cure major autoimmune diseases at their source. RheumaGen focuses on editing the human leukocyte antigen (HLA), or immune gene, to develop one-time, curative cell and gene therapies.Explore more
Rheumagen Org Chart
BM
Chief Medical Officer
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Rheumagen your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Rheumagen
Product Launch: Get notified when Rheumagen launches new products
Check if Rheumagen has recently received funding, and reach out quickly before it becomes old news!
Rheumagen, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Rheumagen is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Rheumagen has new funding data
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Rheumagen recently announced quarterly report
Click to see if Rheumagen had a recent Job posting/layoffs
Recommended Actions
Find VP level buyers at Rheumagen
Find more new buyers
Compare Similar Companies to Rheumagen
Compare insights from companies similar to Rheumagen, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Rheumagen is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Rheumagen is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Rheumagen.
Rheumagen financials insights
Gather financial insights about Rheumagen, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2025
Series A
$15M
Rheumagen Tech Stack
A closer look at the technologies used by Rheumagen
Most Recent Scoops
Funding
Funding
Event
Product Marketing, Events, Learning & Development, Software, Bioengineering, Pharmaceuticals, Public Health, Field /Outside Sales, Field Marketing, Healthcare Technology, Patient Experience
Funding
Funding
Funding
Rheumagen News & Media
Beyond Celiac Investments Announces Funding of RheumaGen to Accelerate Treatments Towards a Cure in Celiac Disease
Investment to progress RheumaGen's celiac disease program through early development as a potential transformational gene therapy PHILADELPHIA, Dec. 22, 2025 /PRNewswire/ -- Beyond Celiac Investments (BCI), the venture philanthropy program of Beyond Celiac, has made a Series A-1 preferred...RheumaGen Presents HLA Gene-Editing Preclinical Data for Nearly Universal Autoimmune Disease Target at ACR Convergence 2025 Oral Session
AURORA, Colo., Oct. 28, 2025 /PRNewswire/ -- RheumaGen, Inc., a cell and gene therapy company engineering a new class of therapeutics to cure common autoimmune diseases, today announced groundbreaking preclinical research that supports a nearly universal target for almost all of the...RheumaGen, Inc. Launches with $15 Million Series A Financing to Advance a New Class of HLA Gene-Editing Therapies for Major Autoimmune Diseases
Company focused on editing the human leukocyte antigen (HLA) to transform autoimmunity Lead program, RG0401, in development for treatment-resistant or refractory rheumatoid arthritis (RA), as a one-time, curative treatment AURORA, Colo., Jan. 9, 2025 /PRNewswire/ -- RheumaGen, Inc., a...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Rheumagen
Sign Up For FreeTo access detailed company insights
RheumaGen is a private biotechnology company engineering a new class of therapeutics to cure major autoimmune diseases at their source. RheumaGen focuses on editing the human leukocyte antigen (HLA), or immune gene, to develop one-time, curative cell and gene therapies.... Read More
